Liminatus Pharma股价在聘请Digital Offering进行融资后飙升

英为财情

2025/07/24

Investing.com -- Liminatus Pharma Inc (NASDAQ:LIMN)股价跳涨26.5%，此前这家临床前阶段的生物制药公司宣布已聘请Digital Offering LLC作为其潜在战略性融资的独家配售代理。该公司专注于开发靶向癌症免疫疗法，表示此次合作支持其此前披露的数字资产财库战略评估。Liminatus正在评估现代金融工具以加强其资本结构，潜在的融资计划可能...

网页链接

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/news/2554810427"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2554810427\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2554810427?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-07-24 23:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2554810427","market":"sh","top_or_hot":-1,"title":"Liminatus Pharma股价在聘请Digital Offering进行融资后飙升","media":"英为财情","content":"<div>\n<p>Investing.com -- Liminatus Pharma Inc (NASDAQ:LIMN)股价跳涨26.5%，此前这家临床前阶段的生物制药公司宣布已聘请Digital Offering LLC作为其潜在战略性融资的独家配售代理。\n该公司专注于开发靶向癌症免疫疗法，表示此次合作支持其此前披露的数字资产财库战略评估。Liminatus正在评估现代金融工具以加强其资本结构，潜在的融资计划可能...</p>\n\n<a href=\"https://cn.investing.com/news/stock-market-news/article-93CH-2901738\">网页链接</a>\n\n</div>\n","source":"investing_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Liminatus Pharma股价在聘请Digital Offering进行融资后飙升</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLiminatus Pharma股价在聘请Digital Offering进行融资后飙升\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-24 23:50 北京时间&nbsp;&nbsp;&nbsp;<a href=https://cn.investing.com/news/stock-market-news/article-93CH-2901738><strong>英为财情</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investing.com -- Liminatus Pharma Inc (NASDAQ:LIMN)股价跳涨26.5%，此前这家临床前阶段的生物制药公司宣布已聘请Digital Offering LLC作为其潜在战略性融资的独家配售代理。\n该公司专注于开发靶向癌症免疫疗法，表示此次合作支持其此前披露的数字资产财库战略评估。Liminatus正在评估现代金融工具以加强其资本结构，潜在的融资计划可能...</p>\n\n<a href=\"https://cn.investing.com/news/stock-market-news/article-93CH-2901738\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LIMN","symbol_name":"Liminatus Pharma LLC","start_time":0,"source_url":"https://cn.investing.com/news/stock-market-news/article-93CH-2901738","article_id":"2554810427","we_media_id":null,"thumbnails":[],"rights":{"source":"investing_news","url":"https://cn.investing.com/news/stock-market-news/article-93CH-2901738","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2554810427","pubTimestamp":1753372200,"columns":[],"sourceInfo":{"source_id":"investing_news","name":"英为财情新闻"},"weMediaInfo":null,"summary":"Investing.com -- Liminatus Pharma Inc 股价跳涨26.5%，此前这家临床前阶段的生物制药公司宣布已聘请Digital Offering LLC作为其潜在战略性融资的独家配售代理。Digital Offering作为一家在FINRA和SEC注册的经纪交易商，将协助Liminatus寻找机构投资者和专注于数字资产的投资者，并构建合规的融资解决方案。\"在Liminatus，我们的核心使命是推进癌症的变革性免疫疗法，\"Liminatus的首席执行官Chris Kim表示。与Digital Offering合作使我们能够以纪律性和前瞻性探索战略融资机会——无论是在传统市场还是在不断发展的数字资产领域。","collect":0,"end_time":0,"defaultTopTitle":"investing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LIMN":"Liminatus Pharma LLC","BK4139":"生物科技"},"translate_title":"Liminatus Pharma stock surges after hiring Digital Offering for funding","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LIMN":1},"content_text":"Investing.com -- Liminatus Pharma Inc (NASDAQ:LIMN)股价跳涨26.5%，此前这家临床前阶段的生物制药公司宣布已聘请Digital Offering LLC作为其潜在战略性融资的独家配售代理。\n该公司专注于开发靶向癌症免疫疗法，表示此次合作支持其此前披露的数字资产财库战略评估。Liminatus正在评估现代金融工具以加强其资本结构，潜在的融资计划可能包括可转换债券、与股权挂钩的证券或其他符合美国证券法的替代工具。\nDigital Offering作为一家在FINRA和SEC注册的经纪交易商，将协助Liminatus寻找机构投资者和专注于数字资产的投资者，并构建合规的融资解决方案。\n\"在Liminatus，我们的核心使命是推进癌症的变革性免疫疗法，\"Liminatus的首席执行官Chris Kim表示。\"在我们朝着这一目标努力的同时，我们也在积极采取措施加强我们的资本战略。与Digital Offering合作使我们能够以纪律性和前瞻性探索战略融资机会——无论是在传统市场还是在不断发展的数字资产领域。\"\n该公司强调，目前尚未敲定任何融资交易，任何潜在的资本交易仍需董事会批准并完全符合监管要求。此公告不构成在任何司法管辖区出售证券的要约或购买证券要约的邀请。\n\n本文由人工智能协助翻译。更多信息，请参见我们的使用条款。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}